Search for: "Gemini Industries Inc"
Results 21 - 32
of 32
Sort by Relevance
|
Sort by Date
10 Apr 2017, 1:40 pm
GAO similarly declined to reconsider protests by Analytic Strategies, LLC and Gemini Industries, Inc. [read post]
6 Dec 2016, 10:05 am
After evaluating initial proposals, the DoD excluded the proposals of Analytic Strategies LLC and Gemini Industries, Inc. from the competitive range. [read post]
17 Feb 2016, 10:19 am
Healthcare companies in the Pamlico portfolio include HEALTHCAREfirst, a provider of SaaS solutions and services to home health and hospice agencies; Physicians Endoscopy, a developer, manager and owner of freestanding, single-specialty endoscopic ASCs; and VRI (Valued Relationships Inc.), a provider of telehealth monitoring, monitored medication dispensing and adherence solutions, and medical alert systems. [read post]
8 Feb 2016, 4:23 pm
Asylum, Inc. [read post]
5 Sep 2013, 10:34 am
Gemini Aluminum Corp., 96 Cal. [read post]
26 Feb 2012, 1:17 pm
The managed futures industry will be in New York on April 18th for the NIBA Conference event and on April 19th for the CTA Expo. [read post]
24 Jan 2012, 6:33 pm
Custom Shapes, Inc., 95 Cal. [read post]
5 Jan 2011, 7:52 am
Uniloc USA, Inc. v. [read post]
4 Jan 2011, 4:08 pm
Instruments, Inc. v. [read post]
10 Mar 2010, 6:43 am
Provided for your review/use is this week's snapshot update of key industry news and views highlighting key electronic discovery related stories, developments, and announcements. [read post]
7 Mar 2010, 12:47 pm
Gemini offers no evidence that the alleged industry agreements are in any way comparable to the patents-in-suit. [read post]
18 Jul 2008, 8:34 am
: (GenericsWeb), Eularis analyses most effective generics defence strategies with new pharmaceutical industry report: (GenericsWeb), WIPO symposium to discuss life sciences multilateral environmental agreements: (Daily Dose of IP), Daiichi Sankyo and Ranbaxy confirm deal is binding and final, allay market rumour and speculation: (SmartBrief), Daiichi Ranbaxy takeover and the implications for the future of IP: (Spicy IP), Europe: Cancer Research Therapeutics’ RNAi patent revoked by… [read post]
